News

AddToAny

Google+ Facebook Twitter Twitter

Limitations in evaluating gene editing technology in human embryos

A commonly used scientific method to analyse a tiny amount of DNA in early human embryos fails to accurately reflect gene edits, according to new research led by scientists at Oregon Health and Science University.

The study involved sequencing the genomes of early human embryos that had undergone genome editing using the gene-editing tool CRISPR.

The work calls into question the accuracy of a DNA-reading procedure that relies on amplifying a small amount of DNA for purposes of genetic testing.

In addition, the study reveals that gene editing to correct disease-causing mutations in early human embryos can also lead to unintended and potentially harmful changes in the genome.

Together, the findings raise a new scientific basis for caution for any scientist who may be poised to use genetically edited embryos to establish pregnancies. Although gene-editing technologies hold promise in preventing and treating debilitating inherited diseases, the authors say the new study reveals limitations that must be overcome before gene editing to establish a pregnancy can be deemed safe or effective.

“It tells you how little we know about editing the genome, and particularly how cells respond to the DNA damage that CRISPR induces,” said senior author Shoukhrat Mitalipov.

“Gene repair has great potential, but these new results show that we have a lot of work to do.”

bit.ly/3Jk20QA

Image credit | Science-Photo-Library| iStock

Related Articles

The big question: Are we entering a new era in which mRNA vaccines are the future?

In May, AstraZeneca began the worldwide withdrawal of its COVID-19 vaccine, due to a “surplus of updated vaccines” that target new variants. Then in June, Moderna announced positive late-stage trial results for its single COVID/flu combination vaccine, mRNA-1083. On the back of this, we look at the future impact of mRNA vaccines.

Breast cancer CREDIT - Science Photolibrary- C0584739

Predicting the return of breast cancer

Dr Isaac Garcia-Murillas discusses a new blood test that can predict if breast cancer will return years before the disease shows on scans.

Restless leg syndrome - CREDIT Science Photolibrary- C0309748

Study points to potential treatments for restless leg syndrome

Scientists have discovered genetic clues to the cause of restless leg syndrome. The discovery could help identify those individuals at greatest risk of the condition and point to potential ways to treat it.

Stem cell transplant and cellular therapy lab

My lab: stem cell transplant and cellular therapy lab

Advanced Specialist Biomedical Scientist Mel Green gives a guided tour of the stem cell transplant lab at Nottingham University Hospitals.

Top